Categories

Extracting your own DNA

Extract your own DNA at home! DNA, or Deoxyribonucleic acid, is the hereditary information in humans and most other plants and animals.  Nearly every cell in a person’s body has the same DNA.  It is made up of four chemical bases called adenine (A), cytosine (C), guanine (G), and thymine (T). Human DNA consists of…

Continue Reading

  To date Myriadians across the country have successfully walked, fundraised and educated colon, ovarian, and breast cancer survivors and caregivers in 7 NOCC Walks to Break the Silence on Ovarian Cancer, 1 Colon Cancer Alliance (CCA) Undy 5000 and 1 Bright Pink FabFest. For all nine events a total of $10,680 has been raised…

Continue Reading

Not many of us can look at a genetic code and be inspired to create artwork from it. For most people a DNA sequence looks like a jumble of letters, wavelengths and bright colors. Max Nanis, however, is not “most people.” Max has married his artistic and scientific backgrounds into a project that he is…

Continue Reading

MELANOMA MONDAY Know Your Risk Skin cancer is one of the most common form of all cancers. Though accounting for less than 5% of all skin cancers, melanoma is the most serious form of skin cancer responsible for the majority of skin cancer attributed deaths. The American Cancer Society estimates that there will be approximately…

Continue Reading

We’re in the business of saving lives.  That’s what really matters to me, and to the very bright people who work with me at Myriad.  We offer testing for patients who, based on their family history, are concerned they are at increased genetic risk for cancer.  If a woman learns from our test that she…

Continue Reading

“When I was in high school, my mom was diagnosed with breast cancer at age 42. She had a lumpectomy, chemo, and radiation. Every year since then, I would get that twinge of nervousness when she had her yearly mammogram…but the more years that went on, it would get a little easier because I had…

Continue Reading

As the shortest month of the year draws to a close, it’s important to remember that it takes longer than 28 days to prevent the impact of cancer on your life and the lives of your loved ones.  There are several life habits you can practice to improve your health and reduce your risk of…

Continue Reading

February 6, 2013 RE: COLARIS® and COLARIS AP® MYH Enhancements Myriad Genetic Laboratories, Inc. is pleased to announce enhancements to our COLARIS® and COLARIS AP® testing for Lynch syndrome and Polyposis syndromes. These important enhancements demonstrate our ongoing commitment to providing the most accurate and complete testing services possible for common hereditary cancer syndromes. COLARIS…

Continue Reading

For the past few years, Myriad has partnered with NSGC to host three genetic counseling student interns during the summer. The positive feedback resulting from that program inspired us to expand the program this year to include a student from each of the training programs in the United States.  We were thrilled this summer to…

Continue Reading

For the past few years, Myriad has partnered with NSGC to host three genetic counseling student interns during the summer. The positive feedback resulting from that program inspired us to expand the program this year to include a student from each of the training programs in the United States.  We were thrilled this summer to…

Continue Reading

Myriad RBM to Perform Protein Biomarker Discovery on Over 8,000 Serum Samples From Patients With Pre-Diabetes or Type 2 Diabetes SALT LAKE CITY, Dec. 10, 2012 (GLOBE NEWSWIRE) — Myriad Genetics (Nasdaq:MYGN) announced today that Myriad RBM, a wholly owned subsidiary of Myriad Genetics, has entered into a research collaboration with Sanofi, a global and diversified healthcare leader, andPopulation Health…

Continue Reading

SALT LAKE CITY, Nov. 28, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled “CCP Score Significantly Predicts PSA Failure After EBRT,” was presented on Wednesday, November 28th, 2012 at the Annual Meeting of the Society of Urological Oncology in Bethesda, Maryland. The study demonstrates that the Prolaris® test, which measures cell cycle progression (CCP) genes, significantly predicts PSA…

Continue Reading

Myriad Genetics is being featured in the November edition of Forbes Magazine! Read the article online HERE and grab a copy when it hits newsstands on November 5th  — Natalie VavrasekInteractive Associate Product Manager

Continue Reading

Leslie had everything planned for her upcoming Thanksgiving feast. Her Christmas shopping lists were in order, and she was ready to host the rehearsal party for her son’s December 28th wedding. What she wasn’t ready for, was the unexpected arrival of cancer. In the 1970s I lost both of my parents to cancer. They were…

Continue Reading

Hi my name is Rebecca and I want to welcome you to the Myriad Genetics Blog! We wanted to share with you all some interesting things we are doing here and will also include some things our friends are talking about. We expect to cover many different topics including research work being done at Myriad, patient…

Continue Reading